| 2025 | Rare bone diseases in Korea: Current Challenges and Future Directions | |
| 2025 | Tailoring osteoporosis treatment: a task force update on goal-driven strategies | |
| 2025 | Managing the Discontinuation of Denosumab in Patients on Hormone Ablative Therapy for Non-metastatic Cancer with Osteoporosis | |
| 2025 | Bridging Pediatric to Adult Endocrine Care:Challenges and Strategies in Transition | |
| 2024 | Management of complications of XLH (Challenging patient case) | |
| 2024 | Bone disease after transplantation:Diagnosis, prevention and treatment | |
| 2024 | Recent Updated Studies in Romosozumab : What’s New? | |
| 2024 | Hypophosphatemic Disorders/Optimizing Treatment Regimen in Patients with Very High Fracture Risk | |
| 2024 | Clinical and Genetic Characteristics of Adult Hypophosphatasia in a Korean Cohort: A Case Series Study | |
| 2024 | Efficacy and Safety of Weekly Liquid Alendronate in Korean Postmenopausal Women with Osteoporosis: A 12-month, Multi-Center, Randomized Trial | |
| 2024 | Treat-to-target Strategy of Osteoporosis Treatment | |
| 2024 | Phosphate Wasting Disorders for the Metabolic Bone Clinicians, Identifying and Treating Before It Is Too Late! | |
| 2024 | Nurturing the next generation: challenges for young endocrinologists in Korea | |
| 2023 | Treatment pattern of osteoporosis in postmenopausal women | |
| 2023 | Treatment pattern of osteoporosis in postmenopausal women using OMOP CDM : a multi-center study | |
| 2023 | Food for thought on the therapeutic regimen after stopping denosumab in postmenopausal women | |
| 2023 | Year in Bone | |
| 2023 | Treatment pattern of osteoporosis in postmenopausal women using OMOP CDM | |
| 2023 | Treatment pattern of osteoporosis in postmenopausal women | |
| 2023 | Romosozumab after denosumab improves lumbar spine bone mineral density and microarchitecture greater than denosumab continuation in postmenopausal women | |
| 2023 | Romosozumab – The dawn of a new era for Osteoporosis | |
| 2023 | Romosozumab – The dawn of a new era for Osteoporosis | |
| 2023 | 2023 골다공증 대국민 인식조사 결과 발표 및 골밀도검사 활성화 중요성 | |
| 2023 | Case-centered treatment of osteoporosis in non-responding patients | |
| 2023 | Genotype-phenotype analysis and long-term clinical outcome of multiple endocrine neoplasia (MEN1)-related pancreatic neuroendocrine tumor(PNET) | |
| 2022 | Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing | |
| 2022 | Romosozumab versus teriparatide in premenopausal women with idiopathic osteoporosis | |
| 2022 | Increased Risk of Incident Diabetes After Therapy with Immune Checkpoint Inhibitor Compared to Conventional Chemotherapy: A Longitudinal Trajectory Analysis Using a Tertiary Care Hospital Database. | |
| 2022 | Romosozumab in premenopausal women with idiopathic osteoporosis: a case series of 7 patients | |
| 2019 | Serum calcium level can be useful to identify primary aldosteronism caused by aldosterone-producing adenoma | |
| 2017 | Determinants of insulin resistance and bone mass: Area, strength, or composition of muscle? | |
| 2015 | Serum calcium level can be useful to identify primary aldosteronism caused by aldosterone-producing adenoma | |
| 2014 | Oxidative stress markers ?in primary aldosteronism | |
| 2013 | Revelation of saline-loading test combined with clinical prediction scoring in verifying Conn’s syndrome | |
| 2012 | Gender-Dependent Skeletal Effects of Vitamin D Deficiency in a Younger Generation | |
| 2012 | BMD below the expected age range in Healthy Premenopausal Women: The The Korea National Health and Nutrition Examination Survey 2008-9 | |
| 2012 | Aldosterone Independently activates parathyroid hormone in primary aldosteronism | |
| 2007 | 건강한 성인에서 자외선 B로 활성화된 비타민 D와 FGF-23의 연관성 | |
| 2007 | 한국인 폐경 후 여성에서 골흡수 억제제 투여에 대한 순응도, 효과 및 영향인자 분석 | |
| 2006 | 부갑상선호르몬의 작용과 Wnt/β - catenin 신호전달체계와의 관련성 규명 | |
| 2004 | 폐경 후 골다공증 환자에 대한 Alendronate와 Calcitriol 복합제 6개월 투여에 대한 무작위 배정, 다기관 공동, 이중 위약 대조군과의 비료 임상 결과 | |
| 2004 | 난소절제 백서에서 부갑상선호르몬 유도체, Unacetylated AibPTH (1-14)의 투여효과 | |
| 2004 | 난소절제 백서에서 맥관형성억제제의 골대사에의 영향 | |
| 2003 | 골다공증에 대한 WHO 진단기준의 정량적 골초음파에의 적용 | |
| 2003 | 한국인에서의 25(OH)D 상태분석 및 골밀도와의 상관관계 조명 | |
| 2002 | 건강한 한국남성에서의 남성호르몬, 인슐린저항성 및 hsCRP간의 연관성 | |
| 2002 | 난소절제백서에서 유전자재조합 인간 부갑상선호르몬(1-84) 치료후 순차적 졸레드로네이트 투여로 증진된 골밀도 유지효과 | |
| 2001 | 폐경전 및 폐경후 건강한 여성들에 있어 혈장 leptin농도와 골밀도와의 상관관계 대한 고찰 | |
| 2001 | 남성갱년기 진단에 있어서 ADAM questionnaire와 생화학적 기준간의 연관성에 대한 고찰 | |
| 2000 | 영양결핍백서에서 유전자재조합 인간 부갑상선호르몬(rhPTH1-84)투여가 골대사에 미치는 영향 | |
http://orcid.org/0000-0003-4227-5638
(7102441193)
